A spin-out company from the universities of Glasgow and Oxford has raised £4.3 million in seed funding to help develop precision antibiotic therapies.
More from us
Did you know with a Digital Subscription to The Scotsman, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more.